Amgen-backed immuno-oncology spinout Immatics has gone public through a reverse merger with special purpose acquisition company Arya Sciences.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Inozyme ignites IPO proceedings
Novo and Sanofi are among the investors that could exit the mineralisation disease therapy developer, which has filed to raise up to $86.3m.
Payfazz picks up $53m series B
BRI Ventures was part of a consortium that provided $53m for mobile wallet developer Payfazz, which also counts Telkom Indonesia as an investor.
Instacart increases latest round to $325m
The American Express, Comcast and Amazon-backed shopping service is valued at $13.8bn having raised $100m from T.Rowe Price for its latest round.
Bharti and UK win $1bn OneWeb auction
The bankrupt satellite internet system developer, which had raised more than $3bn from multiple corporates, has been acquired by a consortium including existing investor Bharti.
Velodyne visualises reverse merger
A year after reportedly hiring banks for an IPO, multi-corporate-backed Velodyne has instead chosen a reverse merger to list on the New York Stock Exchange.
CF PharmTech sees its way to $50m
Drug developer CF PharmTech has raised $50m in an SAIC-backed series F round just six months after closing $90m in series E funding.
Google points North to acquisition
Google paid a reported $180m for Amazon and Intel-backed North Wearables, the augmented reality glasses developer having sought a buyer since spring.
Bolt Biotherapeutics latches onto series C financing
Novo, Pfizer and Nan Fung helped provide $93.5m for the cancer treatment developer as it advances its lead product candidate towards the clinic.
Shift gears up for reverse merger
The Lithia Motors, BMW and Alliance Ventures-backed automotive e-commerce marketplace is set to go public through a reverse merger with Insurance Acquisition.
Mirror reflects on $500m acquisition
At-home fitness company Mirror is set to be acquired by Lululemon for $500m, after the corporate contributed to its series B round in November.
Empower to purchase Personal Capital for $825m
BBVA, USAA and Power Financial are set to exit wealth management technology provider Personal Capital in an $825m transaction.
Byju’s betters $10bn valuation
The BCC, Naspers and Tencent-backed online education provider has reportedly pushed its valuation to $10.5bn following a sub-$100m investment from Bond.
Novo gets in Freeline for $120m round
The pharmaceutical company co-led a series C round for AAV gene therapy developer Freeline that took its total funding to $275m.